About Lysine BioTech
Lysine BioTech is a Healthcare company based in Thanjavur (India) founded in 2018 by Anandagopu Perumal. Generic and biosimilar drugs are manufactured by Lysine BioTech. Lysine BioTech offers products and services including CAR T Cells, Gene Therapy, Biosimilars, Vaccines, and Metabolomic Informatics. Its focus areas include Diversified Pharmaceuticals and Drugs. Its legal entity in India is Lysine Biotech Private Limited (U74999TN2018PTC122879).
Company details
Lysine BioTech was founded in 2018 by Anandagopu Perumal in Thanjavur, India. Operations are focused on the pharmaceutical sector, where generic and biosimilar drugs are produced. Manufacturing activities are based in India, emphasizing cost-effective alternatives to branded pharmaceuticals. Distribution and development efforts are conducted to support healthcare accessibility in regional markets. The companys structure centers on regulatory compliance and quality standards in drug production.
- Headquarters Thanjavur, India
- Founders Anandagopu Perumal
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lysinebiotech.com
- Legal Name Lysine Biotech Private Limited
- Date of Incorporation 24 May, 2018
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹7,850
FY 2022 · -99% YoY
- EBITDA-₹1,460
FY 2022 · -19% margin
Associated legal entities of Lysine BioTech
Lysine BioTech operates through Lysine Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lysine Biotech Private Limited CIN U74999TN2018PTC122879 | Active | 24 May 2018 | Chennai, Tamil Nadu | ₹0.0 Cr | 4 | View details |
Products & Services of Lysine BioTech
Lysine BioTech offers a comprehensive portfolio of products and services, including CAR T Cells, Gene Therapy, Biosimilars, Vaccines, and Metabolomic Informatics.
Develops affordable CAR T cells for cancer and immune treatments.
Provides gene therapy solutions for various human diseases.
Creates cost-effective biosimilars as alternatives to original biologics.
Manufactures vaccines from proteins and DNA for disease prevention.
Analyzes natural products for antibiotics and industrial applications.
Board of directors of Lysine Biotech Private Limited (Lysine BioTech)
Lysine Biotech Private Limited is the primary company behind Lysine BioTech. The board of Lysine Biotech Private Limited currently have 4 directors; the longest-serving is Anandagopu, appointed in 2018. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anandagopu DIN 08141477 | Managing Director | 24 May 2018 | 8 yrs 5 mo | Lysine Biotech Private Limited |
| Arigovindan Panchalai DIN 08721964 | Director | 14 Mar 2020 | 6 yrs 8 mo | Lysine Biotech Private Limited |
| Debapriya Dasgupta DIN 00763766 | Director | 02 Jan 2023 | 3 yrs 10 mo | Lysine Biotech Private Limited |
| Amit Kumar Lahoti DIN 01149657 | Director | 02 Jan 2023 | 3 yrs 10 mo | Lysine Biotech Private Limited |
People of Lysine BioTech
1 people are tracked at Lysine BioTech (1 in leadership).
| Name | Role | Group |
|---|---|---|
Anandagopu Perumal | Founder | Leadership |
Complete people profiles for Lysine BioTech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Lysine BioTech
Figures of Lysine Biotech Private Limited, the primary company behind Lysine BioTech, for FY 2022. Revenue was ₹7,850 (-99% year on year). EBITDA was -₹1,460 (-19% margin).
- ₹7,850Revenue · FY 2022 · -99% YoY
- -₹1,460EBITDA · -19% margin
- ₹7 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Lysine Biotech Private Limited are on its company page.
Detailed financial statements for Lysine BioTech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lysine BioTech
Lysine BioTech was founded in 2018.
Lysine BioTech is headquartered in Thanjavur, India. It is registered at Thanjavur, Tamil Nadu, India.
The primary company behind Lysine BioTech, Lysine Biotech Private Limited, reported revenue of ₹7,850 for FY 2022, down 99% year on year.
Lysine BioTech was founded in 2018 by Anandagopu Perumal in Thanjavur, India. Operations are focused on the pharmaceutical sector, where generic and biosimilar drugs are produced. Manufacturing activities are based in India, emphasizing cost-effective alternatives to branded pharmaceuticals. Distribution and development efforts are conducted to support healthcare accessibility in regional markets. The companys structure centers on regulatory compliance and quality standards in drug production.
Lysine BioTech offers CAR T Cells, Gene Therapy, Biosimilars, Vaccines, and Metabolomic Informatics.
Lysine BioTech operates through Lysine Biotech Private Limited.
The legal entities of Lysine BioTech currently have 4 directors, including Anandagopu, Debapriya Dasgupta, Arigovindan Panchalai and others.